Hypopharyngeal Cancer With Rare Breast Metastasis – A Case Report
Journal Title: PARIPEX-Indian Journal of Research - Year 2015, Vol 4, Issue 4
Abstract
Metastatic squamous cell carcinoma of the breast from primary hypopharynx is very rare, so far has not been reported in the literature. We report a case of a 50-year-lady who presented with hypopharyngeal primary and lump in the left breast. Prognosis is uncertain due to its rarity.
Authors and Affiliations
Dr Naveen Thimmaiah, Dr AshaLatha Devalla, Dr Balu Sadasivan, Dr Lokesh Vishwanath, Dr. Siddanna Palad, Dr Ajay Gubbi Vijaykumar, Dr Tanvir Pasha
Keywords
Related Articles
- EP ID EP571633
- DOI -
- Views 97
- Downloads 0
Histopathological Pattern of Colorectal Tumour – A Hospital Based Study
Introduction:Colorectal carcinoma is a disease of global distribution, however having a commendable identity in the developed western countries. The risk factors like diet, obesity and lack of physical activities are asc...
Traumatic Cerebellar Hematoma: A Single Institute Experience
Background-Traumatic cerebellar hematoma(TCH)is rare, but they are important cause of morbidity and mortality. Method-Thisretrospective study was conducted over two years on patients of head injury at a tertiary care cen...
Effect of Eight Weeks Jalandhar Bandh Practice on Physiological Variables of College Youths.
Jalandhar bandha is one of the three important Bandhas which are essentially required to be performed during Kumbhaka in Pranayama. Excessive pressure is developed in the lungs during Kumbhaka which elevates the blood pr...
PREVALENCE OF CUMULATIVE TRAUMA DISORDERS IN SCULPTORS OF KUMARTULI,WEST BENGAL
BACKGROUND: Cumulative trauma disorders (CTDs), or repetitive stress injuries (RSIs), affect the upper extremities of many workers as they routinely perform their job. OBJECTIVE: The purpose of this study was to investig...
TO STUDY THE CLINICAL AND PATHOLOGICAL STAGING OF BREAST CANCER AND TO CORRELATE THESE FINDINGS WITH STATUS OF THE TUMOR MARKERS
INTRODUCTION : The breast cancer markers that are most important in determining therapy are estrogen receptor, progesterone receptor, and HER-2/neu. Clinicians evaluate clinical and pathologic staging and the expression...